ketoconazole and rifamycins

ketoconazole has been researched along with rifamycins in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyer, C1
Capoccia, E; Cirillo, C; Cuomo, R; D'Alessandro, A; Esposito, G; Gigli, S; Nobile, N; Pesce, M; Sarnelli, G; Seguella, L; Steardo, L1

Other Studies

2 other study(ies) available for ketoconazole and rifamycins

ArticleYear
A banner year for AIDS therapy.
    The American journal of nursing, 1993, Volume: 93, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Atovaquone; HIV Infections; Humans; Itraconazole; Ketoconazole; Naphthoquinones; Rifabutin; Rifamycins; United States; United States Food and Drug Administration; Zalcitabine

1993
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
    International journal of oncology, 2016, Volume: 49, Issue:2

    Topics: Anti-Bacterial Agents; Caco-2 Cells; Cell Movement; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Ketoconazole; Neoplasm Proteins; Neovascularization, Pathologic; Pregnane X Receptor; Proliferating Cell Nuclear Antigen; Receptors, Steroid; Rifamycins; Rifaximin; Signal Transduction

2016